Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Compounding is essential for effective wealth building. Discover why it matters and how to incorporate it into your financial plans.
21,125 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Tesla faces a fresh wave of headwinds as policy, competition, and software bets collide with a fragile growth narrati...
Raymond James raises its price target on Phillips 66 to $205, citing a peak in refining margins and geopolitical tail...
The FHFA has directed Fannie Mae to accept cryptocurrency as mortgage reserves, but a steep haircut on crypto holding...
Netflix walked away from a blockbuster deal, yet it still raised prices. This personal-finance guide explains what ha...
The U.S. debt held by the public has eclipsed nominal GDP for the first time since World War II, a milestone that cou...
Investing hinges on leadership as much as numbers. This guide dives into how Josh D'Amaro's new approach could influe...
Bruker's Q1 2026 earnings transcript can reveal much about the stock's path in 2026. This guide breaks down what to l...
MP Materials is shaping the materials landscape with its Mountain Pass operation. This guide breaks down what to wat...
A sudden price glitch on a popular trading app sent bitcoin price crashes near zero for a moment, leaving traders puz...
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...
Institutional investors are eyeing Millrose Properties’ land-banking model as the housing market shifts. This look at...